Arbutus Biopharma Corp (ABUS) Хувьцааны үнэ ба Мэдээ

НүүрABUS • NASDAQ

Arbutus Biopharma Corp

$ 4.26

3-р сарын 16, 08:20:34 (GMT-4) · USD · NASDAQ · Үгүйсгэсэн мэдэгдэл

ХувьцааАНУ-д жагсаасан үнэт цаасАНУ-д удирдах төвтэй

Өмнөх хаалт

$ 4.26

Жилийн хүрээ

$ 2.71 - $ 5.10

Хувьцааны нийт дүн

819.30 сая USD

Дундаж хэмжээ

2.67 сая

Ү/А харьцаа

Ногдол ашиг

Үндсэн валют арилжаа

NASDAQ

Зах зээлийн мэдээ

Yahoo Finance

17 минутын өмнө

JFB (NASDAQ: JFB) Announces XTEND and Rayonix Execute Exclusive Manufacturing and Distribution Agreement with Initial $11 Million Commitment to Expand XOS Platform into India.

Fresno Bee

38 минутын өмнө

New to The Street Broadcasts Episode Featuring FreeCast (NASDAQ:CAST), KLED.AI, PetVivo (OTCQB:PETV), EmpowerLit, and BlackBarn NYC on Bloomberg Television - March 21 at 6:30 PM EST

Quipt Home Medical (NASDAQ: QIPT) delists common shares via Form 25

Trump has 15 days to end the Iran war or markets face a brutal April repricing — from oil to the S&P 500

Severe oil shock could drag S&P 500 down to 5,400, Goldman warns

How do companies get added to (& dropped from) the Dow? The averages committee explained

.DJI

0.00%

Тухай

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

Гүйцэтгэх захирал

William H. Collier

Үүсгэн байгуулагдсан

2007

Төв байр

Warminster Township, Пеннсилвани
Америкийн Нэгдсэн Улс

Вебсайт

arbutusbio.com

Ажилчид